in the isolated general practitioner units." Taking the results to a logical conclusion, the only really safe place for women to deliver in Bath health district is in the integrated general practitioner unit, which is much safer than the consultant unit. Study of perinatal mortality rates for the districts within Wessex region for the four years 1986-9 shows considerable variation both year to year within the units and, when the average figures for the four years are calculated, among the units. The average perinatal mortality rates for Bath health district for the four years is 8-7 per 1000 births; the figures for Wessex and England and Wales are 8 7 and 8-9 per 1000 respectively. Comparison of crude perinatal mortality rates is known to have many pitfalls. Corrections to exclude congenital malformations, low birth weight, and multiple births may help to reduce such difficulties, but it is facile to suggest that quality of antenatal and intrapartum care is the only reason for differences in outcome among maternity units.
Antepartum asphyxia was the commonest fetal factor in both consultant and isolated general practitioner units. That poor antenatal care is responsible cannot be determined without a detailed study of each case. Furthermore, distance from the central unit is probably an important factor in the outcome of some antepartum morbidity. Excluding antepartum asphyxia from the data, we wonder at the significance of the figures as the numbers are so small.
For 10 years the isolated and integrated units have each produced detailed annual reports, which have been used for local audit and discussed at meetings of the maternity advisory committee. The consultant unit is the only unit not to produce such a report. We have long called for a comprehensive data collection system for the district so that intervention, morbidity, and outcome can be properly analysed. We propose a properly constructed prospective study to include socioeconomic factors.
We value constructive scrutiny of the quality of our maternity care, but alarmist and poorly constructed argument devalues debate. Furthermore, the sensational and uncritical way the paper has been reported in the local press accompanied by the high profile presentation of the views of one of the authors can be seen only as an attempt to undermine the confidence of local mothers. Some mothers, however, will continue to prefer to deliver in small friendly maternity units in which the emphasis is on continuity of care, low intervention-, and high quality of postpartum care. Safety is one of several considerations for all those concerned with the quality of maternity care. Reducing the number of preventable perinatal deaths is undeniably important. We acknowledge our responsibility to maintain our obstetric and neonatal skills but we believe that irresponsible criticism is unhelpful and unwarranted. Shetland is a prime example of the difficulties created by geographical location. The nearest consultant obstetric unit to Shetland is Aberdeen, a distance of 320 km by sea. Thus general practitioners in Shetland have to undertake full maternity care for all expectant mothers unless some obvious risk factor presents itself at booking or during the antenatal period which dictates that the patient should be electively sent to Aberdeen for delivery.
The authors make two comments with which I would entirely agree: firstly, "All general practitioner obstetricians should be skilled in neonatal resuscitation" and, secondly, "Surely it should not be possible to practise intrapartum care without training in obstetrics as a senior house officer for six months and training in neonatal paediatrics."
Some of us have undertaken this very basic training. I was a senior house officer in obstetrics in a reasonably busy district general hospital for six months and this was followed by four months in neonatal paediatrics. It is all very well, however, to have had some basic grounding, but, clearly, to ensure that general practitioners practise competently they must have regular, continuing exposure to practical intrapartum experience in the labour room.
My partner and I are responsible for an average of 30 deliveries a year at our local maternity hospital, the patients who have identifiable risk factors having already been referred. As everyone who undertakes maternity care knows, even with the most careful selection of patients things can surprisingly go amiss during labourfor example, the impacted shoulder, the retained placenta, the unexpected delayed second stage, the asphyxiated baby, the undiagnosed breech that, although it should not happen, does even in the best of units. Because of the small population and the fact that the mothers are a low risk group we may only come across one of these complications once every few years, but the important point is that it could occur at any time and the general practitioner must be ready and able to cope as the need arises. If Effect of erythropoietin in patients with myeloma SIR,-Dr J Taylor and colleagues report similar results in two patients with multiple myeloma' to those of Ludwig et a?: an improvement in haemoglobin concentration but no stimulation of the malignant plasma cell clone. We would like to report a recent case in which a temporary increase in urinary excretion of X light chain was associated with erythropoietin.
In 1987 a 51 year old man presented with renal failure and urinary excretion of light chains of 7-67 g/l. After treatment with melphalan and prednisolone and subsequently with four courses of vincristine, adriamycin, and methylprednisolone (VAMP) he achieved plateau phase with a urinary excretion of light chains of 4 g/l but continued to require haemodialysis. After a relapse in 1988 he was treated with VAMP supplemented by verapamil. Once the plateau phase was achieved he was maintained on interferon alfa (Intron A). In August 1989 because of severe anaemia he was started on erythropoietin (4000 units twice weekly). This resulted in a rise in haemoglobin concentration from 80 g/l to 104 g/l, but his urinary excretion of light chains rose from 1-56gAl to 10 75g/l, subsequently falling to the previous levels when the erythropoietin was discontinued. During this time he was maintained on interferon alfa and received no other treatment for his myeloma.
The 
